CF Research Innovation Awards
Forecasted
The CF Research Innovation Awards from Vertex Pharmaceuticals support early-career researchers advancing innovative cystic fibrosis science through independent or mentored research projects.
Browse similar grants
Funder: Vertex Pharmaceuticals
Due Dates (Anticipated): June 2026 (CF Research Innovation Awards application submission deadline; projected)
Funding Amounts: Independent Research: $750,000 over 3 years (up to 2 awards annually); Mentored Research: up to $125,000 over 2 years (up to 4 awards annually)
Summary: Highly competitive awards supporting early-career researchers advancing cystic fibrosis science through independent and mentored research.
Key Information: This is a forecasted cycle; all dates are projected and subject to change.
Description
The CF Research Innovation Awards, funded by Vertex Pharmaceuticals, are designed to inspire and support emerging M.D.s and Ph.Ds. in cystic fibrosis (CF) research. The awards aim to advance scientific understanding of CF and help early-career investigators establish themselves as leaders in the field. The program offers two categories:
- Independent Research: For newly independent faculty launching promising research programs.
- Mentored Research: For collaborative projects between early-career investigators and established CF researchers.
Applications are evaluated by an independent steering committee to ensure scientific merit and innovation.
